• 1
    Pagano L, Candoni A, Caira M et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM B – 2004 study. Haematologica2006; 91: 10681075.
  • 2
    Baddley JW, Andes DR, Marr KA et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis2010; 50: 15591567.
  • 3
    Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic stem cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis2007; 44: 531540.
  • 4
    Pagano L, Caira M, Candoni A et al. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica2010; 95: 644650.
  • 5
    Neofytos D, Horn D, Anaissie E et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of multicenter prospective antifungal therapy (PATH) alliance. Clin Infect Dis2009; 46: 265273.
  • 6
    Kontoyiannis DP, Marr KA, Park BJ et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the transplant-associated infection surveillance network (TRANSNET) database. Clin Infect Dis2010; 50: 10911100.
  • 7
    Pagano L, Caira M, Nosari A et al. Hema e-Chart: Italian registry of prospective analysis of epidemiology, management and outcome of febrile events in patients with hematologic malignancies. J Chemother2010; 22: 2024.
  • 8
    Pagano L, Caira M, Nosari A et al. The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the Hema e-Chart project. Haematologica2011; 96: 13661370.
  • 9
    Pagano L, Caira M, Nosari A et al. Etiology of febrile episodes in patients with acute myeloid leukemia: results from the Hema e-Chart registry. Arch Intern Med2011; 171: 15021503.
  • 10
    Pagano L, Caira M, Rossi G et al. A prospective survey of febrile events in haematological malignancies. Ann Hematol2011; 91: 767774.
  • 11
    De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group. Clin Infect Dis2008; 46: 18131821.
  • 12
    Marr KA, Balajee SA, McLaughlin L et al. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis2004; 190: 641649.
  • 13
    Marr KA, Carter RA, Boechk M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood2002; 100: 43584366.
  • 14
    Ramos ER, Jiang Y, Hachem R et al. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant recipients: the role of novel antimold azoles. Oncologist2011; 16: 10491060.
  • 15
    Pagano L, Caira M, Nosari A et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study. Clin Infect Dis2007; 45: 11611170.
  • 16
    Tortorano A, Kibbler C, Peman J et al. Candidemia in Europe: epidemiology and resistance. Int J Antimicrob Agents, 2006; 27: 359366.
  • 17
    Horn DL, Neofytos D, Anaissie EJ et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the Prospective Antifungal Therapy Alliance Registry. Clin Infect Dis2009; 48: 16951703.
  • 18
    Nicolle MC, Bénet T, Thiebaut A et al. Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009. Haematologica2011; 96: 16851691.
  • 19
    Pagano L, Caira M, Picardi M et al. Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality – SEIFEM-C report. Clin Infect Dis2007; 44: 15241525.